Please provide your email address to receive an email when new articles are posted on . BUFFALO GROVE, Ill. — Akorn's abbreviated new drug application for ofloxacin ophthalmic solution 0.3% has been ...
BUFFALO GROVE, Ill. -- Akorn today announced that the U.S. Food and Drug Administration (FDA) has granted approval for Akorn’s Abbreviated New Drug Application (ANDA) for Ofloxacin Ophthalmic ...
Ofloxacin Ophthalmic Solution USP 0.3% is indicated for the treatment of eye infections caused by the conditions of conjunctivitis and corneal ulcers. According to IQVIATM (IMS Health), Ofloxacin ...
https://www.thehindubusinessline.com/markets/caplin-point-labs-subsidiary-gets-usfda-approval-for-ofloxacin-otic-solution-03/article67718608.ece Copy Caplin Point ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results